Logo
x

Search

Subscribe Now

Meitheal Pharmaceuticals

Meitheal Pharmaceuticals Receives Exclusive Commercial Rights of Three Biosimilars Across the US

Meitheal Pharmaceuticals Receives Exclusive Commercial Rights of Three Biosimilars Across the US

  • November 4, 2024
Meitheal Acquires Rights of Nabriva’s Contepo, Expanding its Specialty Biopharmaceuticals Portfolio

Meitheal Acquires Rights of Nabriva’s Contepo, Expanding its Specialty Biopharmaceuticals Portfolio

  • July 19, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.